IBM’s Recovery Test: Can a 42% Mainframe Plunge Be Written Off as a Timing Glitch?

IBM shares surge 2.35% for seventh straight gain, recovering from a historic 25% single-day plunge. Analysts debate whether the rebound signals stabilization or a pause before further decline.

IBM’s stock has clawed back to around €192.80, gaining 2.35% in a single session and notching its seventh consecutive day of advances — a cumulative weekly gain of roughly 7%. For a stock that suffered one of the most violent single-day collapses in the company’s history just weeks ago, the rebound has been swift. But the real question is whether this marks genuine stabilization or merely a pause before another leg lower.

The carnage began in early July, when IBM issued a preliminary earnings warning that caught the market off guard. Second-quarter revenue came in at $17.2 billion, well short of the $17.86 billion consensus. The culprit: corporate clients were diverting budgets away from IBM’s software and infrastructure toward pure-play AI hardware. The stock cratered roughly 25% in a single session — the worst trading day the company has ever recorded.

When the final quarterly numbers landed on July 22, they confirmed the preliminary picture without adding fresh shocks. Revenue and adjusted earnings per share matched the earlier pre-announcement. But the damage was already done, concentrated squarely in the infrastructure segment. Sales of the Z-series mainframe, IBM’s flagship high-end system, collapsed by 42% year-over-year.

The Case for Overreaction

What makes this sell-off unusual is the divergence between the headline numbers and the underlying business lines. While the infrastructure segment took a beating, IBM’s software division grew 5% overall. Within that unit, Red Hat surged 11% and the data business jumped 19%. Consulting held steady. The growth portfolio — Red Hat, watsonx, HashiCorp, Confluent — continued to deliver, even as the mainframe cycle created a drag on the aggregate figures.

Management has been adamant that the mainframe weakness is a timing issue, not a structural defection. CEO Arvind Krishna noted that roughly one-third of the delayed deals had already closed in the third quarter. CFO Jim Kavanaugh was even more emphatic: “We see no evidence that customers are migrating away from the mainframe.” The company expects significant strength in the program during the second half of the year.

Independent analysts broadly concur. One enterprise research director described the 25% single-day plunge as overdone — a symptom of an unusually volatile market and uncertainty about how quickly AI investments will generate returns, rather than a verdict on IBM’s long-term viability.

The Technical Picture Supports the Narrative

The chart tells a story of capitulation, not the start of a sustained downtrend. The relative strength index (RSI-14) currently sits at 38.4 — weak, but a far cry from the extreme oversold readings of 19 to 20 recorded at the crash’s peak. The stock trades just over 10% above its 52-week low of €175.14, which was set as recently as July 23. A fresh low followed by a multi-day recovery is the textbook pattern of a selling climax.

The annualized 30-day volatility of 85.32% underscores just how violent the re-rating was. But such spikes after a shock typically fade as the market digests the news. They rarely intensify.

The Bull Case Has Substance — But Caveats Apply

The mainframe weakness that triggered the panic looks more cyclical than existential. Sales volumes of the new z17 generation are running at nearly 130% of the z16 cycle at the same point. The vast majority of the installed base is either maintaining or increasing capacity — hardly the profile of a business in terminal decline, even if the most recent quarter was ugly.

IBM also has longer-term bets in the pipeline: the Lightwell open-source security initiative and the Anderon quantum foundry project, backed by the CHIPS Act. Both are multi-year stories, not near-term catalysts, but they demonstrate that the company has options beyond the current software-versus-hardware debate.

Still, the bull case is not without risks. For every dollar of mainframe hardware, IBM historically generates three dollars in attached software revenue. A prolonged mainframe slump would therefore cascade into the higher-margin software business — and that software segment grew only modestly in the quarter, missing its own targets. Consulting was essentially flat. This is not an isolated weakness at a single point; it is a slowdown across multiple fronts.

Management trimmed its full-year constant-currency revenue growth forecast to 4% to 5%. That is a downward revision, not a collapse. More importantly, free cash flow is still expected to rise by roughly $1 billion for the full year — the metric that matters most for dividend safety, and one that analysts had been debating intensely before the report.

What Needs to Happen Next

The current stock price of roughly €192 embeds a scenario in which the mainframe weakness proves structural rather than cyclical. If the “delayed, not lost” narrative holds through the second half, the wide gap to the 52-week high and the deeply oversold technical position argue for a stronger recovery than the market currently prices in.

The consensus analyst price target of €231.06 implies upside of roughly 23% from current levels — a gap that reflects genuine skepticism rather than blind conviction about a rapid rebound. A full return to that level will require patience and at least a few more quarters demonstrating that the 4% to 5% growth forecast is actually achievable.

With a year-to-date decline of roughly 26% and a wide gap below the 200-day moving average, IBM is far from a fully repaired stock. But the severity of the crash, followed by the swift partial recovery, supports a more nuanced reading: the core business around Red Hat, watsonx, and data continued to grow, while mainframe timing alone distorted the headline number. For now, the argument that the worst of the re-rating is behind the stock carries more weight than the alternative.